2007
DOI: 10.1128/jvi.01607-06
|View full text |Cite
|
Sign up to set email alerts
|

The Minimal Replicator Element of the Kaposi's Sarcoma-Associated Herpesvirus Terminal Repeat Supports Replication in a Semiconservative and Cell-Cycle-Dependent Manner

Abstract: Kaposi's sarcoma-associated herpesvirus (KSHV) persists as episomes in infected cells by circularizing at the terminal repeats (TRs).Kaposi's sarcoma-associated herpesvirus (KSHV), discovered using a subtractive hybridization technique from the Kaposi sarcoma lesions, is also associated with at least two lymphoproliferative diseases, primary effusion lymphoma (PEL) and multicentric Castleman's disease (9-11, 17, 54, 59). KSHV persists as multicopy episomal DNA in infected cells with the expression of a small s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
39
0

Year Published

2008
2008
2014
2014

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(41 citation statements)
references
References 67 publications
(120 reference statements)
2
39
0
Order By: Relevance
“…ChIP assays. A chromatin immunoprecipitation (ChIP) assay was performed as described previously (68). Briefly, 1 ϫ 10 6 293/Bac36 cells transfected with TLE2 were used per assay.…”
Section: Methodsmentioning
confidence: 99%
“…ChIP assays. A chromatin immunoprecipitation (ChIP) assay was performed as described previously (68). Briefly, 1 ϫ 10 6 293/Bac36 cells transfected with TLE2 were used per assay.…”
Section: Methodsmentioning
confidence: 99%
“…DNA methylation is one of the strategies that some viruses use to avoid detection by the immune system (Butel, 2000;Verma et al, 2007); specifically, the deregulation of DNMT family members has been proposed as one of the mechanisms that modulate gene expression in these interactions (Li et al, 2005). Therapy with demethylating agents in this kind of pathology has not yet been used against solid tumors in vivo, but for example, DNMT3B inhibitors could potentially be useful in HCC (Park et al, 2007a).…”
Section: Discussionmentioning
confidence: 99%
“…LANA participates in the maintenance of the episome during latency. It also links the episome to the host cell chromosome and binds to the viral repeat elements (TR) of the viral genome to mediate its replication (Ballestas et al, 1999;Cotter and Robertson, 1999;Verma et al, 2007). The interactions between LANA and cellular and viral proteins, such as those encoded by p53, pRB or replication and transcription activator (Rta), among others, are summarized by zur Hausen (2006), who also reviews its regulatory role in the expression of genes involved in the main cellular pathways.…”
Section: Viral Epigenomes In Human Tumorigenesis Af Fernandez and M Ementioning
confidence: 99%
“…1A and C). Given that the synthesis of KSHV genomes is licensed (22), these observations likely indicate that a higher number of TRs provides KSHV plasmids with an increased probability that they will undergo synthesis.…”
Section: Resultsmentioning
confidence: 99%
“…The MRE, consisting of two LANA1-binding sites (LBS 1 and 2) and an upstream GC-rich replication element (RE), is the minimal element that supports synthesis of KSHV plasmids (17). LANA1 mediates licensed synthesis of the viral plasmid by binding to LBS 1 and 2 through its DNA-binding and dimerization domain located in the C terminus and recruiting the cellular origin recognition complex (ORC) (18)(19)(20)(21)(22). The partitioning of KSHV plasmids is thought to be mediated by tethering of viral plasmids to cellular chromosomes by LANA1.…”
mentioning
confidence: 99%